Cargando…
Squamous cell carcinoma antigen (SCCA) is up-regulated during Barrett’s carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapy
Squamous Cell Carcinoma Antigen (SCCA) is consistently overexpressed in many different solid tumors, and has been associated with both tumor aggressiveness and chemoresistance. No data, however, is currently available on SCCA expression during esophageal Barrett's carcinogenesis, nor on SCCA ex...
Autores principales: | Fassan, Matteo, Realdon, Stefano, Vianello, Luca, Quarta, Santina, Ruol, Alberto, Castoro, Carlo, Scarpa, Marco, Zaninotto, Giovanni, Guzzardo, Vincenza, Sileni, Vanna Chiarion, Pontisso, Patrizia, Rugge, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421854/ https://www.ncbi.nlm.nih.gov/pubmed/28042960 http://dx.doi.org/10.18632/oncotarget.14108 |
Ejemplares similares
-
Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity
por: Turato, Cristian, et al.
Publicado: (2019) -
PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019) -
Role of Proton Pump Inhibitor on Esophageal Carcinogenesis and Pancreatic Acinar Cell Metaplasia Development: An Experimental In Vivo Study
por: Dall’Olmo, Luigi, et al.
Publicado: (2014) -
Genetic Features of Metachronous Esophageal Cancer Developed in Hodgkin’s Lymphoma or Breast Cancer Long-Term Survivors: An Exploratory Study
por: Boldrin, Elisa, et al.
Publicado: (2015) -
CD80 expression promotes immune surveillance in Barrett’s metaplasia
por: Scarpa, Melania, et al.
Publicado: (2019)